Abstract
A role for glucagon-like peptide 1 (GLP-1) has been suggested in stimulating β-cell lipolysis via elevation of cAMP and activation of protein kinase A, which in turn may activate hormone-sensitive lipase (HSL), thereby contributing to fatty acid generation (FFA) from intracellular triglyceride stores. FFAs may then be metabolized to a lipid signal, which is required for optimal glucose-stimulated insulin secretion. Since HSL is expressed in islet β-cells, this effect could contribute to the stimulation of insulin secretion by GLP-1, provided that a lipid signal of importance for insulin secretion is generated. To examine this hypothesis, we have studied the acute effect of GLP-1 on isolated mouse islets from normal mice and from mice with high-fat diet induced insulin resistance. We found, however, that although GLP-1 (100 nM) markedly potentiated glucose-stimulated insulin secretion from islets of both feeding groups, the peptide was not able to stimulate islet palmitate oxidation or increase lipolysis measured as glycerol release. This indicates that a lipid signal does not contribute to the acute stimulation of insulin secretion by GLP-1. To test whether lipolysis might be involved in the islet effects of long-term GLP-1 action, mice from the two feeding groups were chronically treated with exendin-4, a peptide that lowers blood glucose by interacting with GLP-1 receptors, in order to stimulate insulin secretion, for 16 days before isolation of the islets. The insulinotropic effects of GLP-1 and forskolin were exaggerated in isolated islets from exendin-4 treated mice given a high-fat diet, with a augmented palmitate oxidation as well as islet lipolysis at high glucose levels in these islets. Exendin-4 treatment had less impact on mice fed a normal diet. From these results we conclude that while GLP-1 does not seem to induce β-cell lipolysis acutely in mouse islets, the peptide affects β-cell fat metabolism after long-term adaptation to GLP-1 receptor stimulation.
Key words
Insulin secretion - Exendin-4 - Islet - Lipid metabolism
References
-
1
Boden G, Shulman G I.
Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction.
Eur J Clin Invest.
2002;
32
14-23
-
2
Shimabukuro M, Zhou Y T, Levi M, Unger R H.
Fatty acid-induced beta cell apoptosis: a link between obesity and diabetes.
Proc Natl Acad Sci USA.
1998;
95
2498-2502
-
3
Warnotte C, Gilon P, Nenquin M, Henquin J C.
Mechanisms of the stimulation of insulin release by saturated fatty acids. A study of palmitate effects in mouse beta-cells.
Diabetes.
1994;
43
703-711
-
4
Dobbins R L, Chester M W, Stevenson B E, Daniels M B, Stein D T, McGarry J D.
A fatty acid- dependent step is critically important for both glucose- and non-glucose-stimulated insulin secretion.
J Clin Invest.
1998;
101
2370-2376
-
5
Elks M L.
Chronic perifusion of rat islets with palmitate suppresses glucose-stimulated insulin release.
Endocrinology.
1993;
133
208-214
-
6
Sako Y, Grill V E.
A 48-hour lipid infusion in the rat time-dependently inhibits glucose-induced insulin secretion and B cell oxidation through a process likely coupled to fatty acid oxidation.
Endocrinology.
1990;
127
1580-1589
-
7
Lupi R, Dotta F, Marselli L, Del Guerra S, Masini M, Santangelo C, Patane G, Boggi U, Piro S, Anello M, Bergamini E, Mosca F, Di Mario U, Del Prato S, Marchetti P.
Prolonged exposure to free fatty acids has cytostatic and pro-apoptotic effects on human pancreatic islets: evidence that beta-cell death is caspase mediated, partially dependent on ceramide pathway, and Bcl-2 regulated.
Diabetes.
2002;
51
1437-1442
-
8
Grill V, Cerasi E.
Activation by glucose of adenyl cyclase in pancreatic islets of the rat.
FEBS Lett.
1973;
33
311-314
-
9
Schuit F C, Pipeleers D G.
Regulation of adenosine 3′,5′-monophosphate levels in the pancreatic B cell.
Endocrinology.
1985;
117
834-840
-
10
Ahren B.
Glucagon-like peptide-1(7-36)amide increases cyclic AMP accumulation in normal islets.
Pancreas.
1996;
12
211-213
-
11
Gao Z Y, Gilon P, Henquin J C.
The role of protein kinase-C in signal transduction through vasopressin and acetylcholine receptors in pancreatic B-cells from normal mouse.
Endocrinology.
1994;
135
191-199
-
12
Weng L, Davies M, Ashcroft S J.
Effects of cholinergic agonists on diacylglycerol and intracellular calcium levels in pancreatic beta-cells.
Cell Signal.
1993;
5
777-786
-
13
Corkey B E, Glennon M C, Chen K S, Deeney J T, Matschinsky F M, Prentki M.
A role for malonyl-CoA in glucose-stimulated insulin secretion from clonal pancreatic beta-cells.
J Biol Chem.
1989;
264
21608-21612
-
14
Chen S, Ogawa A, Ohneda M, Unger R H, Foster D W, McGarry J D.
More direct evidence for a malonyl-CoA-carnitine palmitoyltransferase I interaction as a key event in pancreatic beta-cell signaling.
Diabetes.
1994;
43
878-883
-
15
Corkey B E, Deeney J T, Yaney G C, Tornheim K, Prentki M.
The role of long-chain fatty acyl-CoA esters in beta-cell signal transduction.
J Nutr.
2000;
130 (2S Suppl)
299S-304S
-
16
Briaud I, Harmon J S, Kelpe C L, Segu V B, Poitout V.
Lipotoxicity of the pancreatic beta-cell is associated with glucose-dependent esterification of fatty acids into neutral lipids.
Diabetes.
2001;
50
315-321
-
17
Segall L, Lameloise N, Assimacopoulos-Jeannet F, Roche E, Corkey P, Thumelin S, Corkey B E, Prentki M.
Lipid rather than glucose metabolism is implicated in altered insulin secretion caused by oleate in INS-1 cells.
Am J Physiol.
1999;
277
E521-E528
-
18
Deeney J T, Tornheim K, Korchak H M, Prentki M, Corkey B E.
Acyl-CoA esters modulate intracellular Ca2+ handling by permeabilized clonal pancreatic beta-cells.
J Biol Chem.
1992;
267
19840-19845
-
19
Larsson O, Deeney J T, Branstrom R, Berggren P O, Corkey B E.
Activation of the ATP-sensitive K+ channel by long chain acyl-CoA. A role in modulation of pancreatic beta-cell glucose sensitivity.
J Biol Chem.
1996;
271
10623-10626
-
20
Yaney G C, Korchak H M, Corkey B E.
Long-chain acyl CoA regulation of protein kinase C and fatty acid potentiation of glucose-stimulated insulin secretion in clonal beta-cells.
Endocrinology.
2000;
141
1989-1998
-
21
Mulder H, Holst L S, Svensson H, Degerman E, Sundler F, Ahren B, Rorsman P, Holm C.
Hormone-sensitive lipase, the rate-limiting enzyme in triglyceride hydrolysis, is expressed and active in beta-cells.
Diabetes.
1999;
48
228-232
-
22
Roduit R, Masiello P, Wang S P, Li H, Mitchell G A, Prentki M.
A role for hormone-sensitive lipase in glucose-stimulated insulin secretion: a study in hormone-sensitive lipase-deficient mice.
Diabetes.
2001;
50
1970-1975
-
23
Mulder H, Sörhede-Winzell M, Contreras J A, Fex M, Strom K, Ploug T, Galbo H, Arner P, Lundberg C, Sundler F, Ahren B, Holm C.
Hormone-sensitive lipase null mice exhibit signs of impaired insulin sensitivity whereas insulin secretion is intact.
J Biol Chem.
2003;
278
36380-36388
-
24
Fex M, Olofsson C S, Fransson U, Bacos K, Lindvall H, Sörhede-Winzell M, Rorsman P, Holm C, Mulder H.
Hormone-sensitive Lipase deficiency in mouse islets abolishes neutral cholesterol ester hydrolase activity but leaves lipolysis, acylglycerides, fat oxidation, and insulin secretion intact.
Endocrinology.
2004;
145
3746-3753
-
25
Holm C, Osterlund T, Laurell H, Contreras J A.
Molecular mechanisms regulating hormone-sensitive lipase and lipolysis.
Annu Rev Nutr.
2000;
20
365-393
-
26
Holst J J, Orskov C.
Incretin hormones - an update.
Scand J Clin Lab Invest Suppl.
2001;
234
75-85
-
27
Thorens B, Porret A, Buhler L, Deng S P, Morel P, Widmann C.
Cloning and functional expression of the human islet GLP-1 receptor. Demonstration that exendin-4 is an agonist and exendin-(9-39) an antagonist of the receptor.
Diabetes.
1993;
42
1678-1682
-
28
Fehmann H C, Bode H P, Ebert T, Karl A, Goke B.
Interaction of GLP-I and leptin at rat pancreatic B-cells: effects on insulin secretion and signal transduction.
Horm Metab Res.
1997;
29
572-576
-
29
Yaney G C, Civelek V N, Richard A M, Dillon J S, Deeney J T, Hamilton J A, Korchak H M, Tornheim K, Corkey B E, Boyd A E 3rd.
Glucagon-like peptide 1 stimulates lipolysis in clonal pancreatic beta-cells (HIT).
Diabetes.
2001;
50
56-62
-
30
Eng J, Kleinman W A, Singh L, Singh G, Raufman J P.
Isolation and characterization of exendin-4, an exendin-3 analogue, from Heloderma suspectum venom. Further evidence for an exendin receptor on dispersed acini from guinea pig pancreas.
J Biol Chem.
1992;
267
7402-7405
-
31
Goke R, Fehmann H C, Linn T, Schmidt H, Krause M, Eng J, Goke B.
Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells.
J Biol Chem.
1993;
268
19 650-19 655
-
32
Nielsen L L, Baron A D.
Pharmacology of exenatide (synthetic exendin-4) for the treatment of type 2 diabetes.
Curr Opin Investig Drugs.
2003;
4
401-405
-
33
Surwit R S, Kuhn C M, Cochrane C, McCubbin J A, Feinglos M N.
Diet-induced type II diabetes in C57BL/6J mice.
Diabetes.
1988;
37
1163-1167
-
34
Ahren B, Simonsson E, Scheurink A J, Mulder H, Myrsen U, Sundler F.
Dissociated insulinotropic sensitivity to glucose and carbachol in high-fat diet-induced insulin resistance in C57BL/6J mice.
Metabolism.
1997;
46
97-106
-
35
Pacini G, Thomaseth K, Ahren B.
Contribution to glucose tolerance of insulin-independent vs. insulin-dependent mechanisms in mice.
Am J Physiol Endocrinol Metab.
2001;
281
E693-E703
-
36
Sörhede Winzell M, Ahren B.
High-fat diet fed mice - a model for studying mechanisms and treatment of impaired glucose tolerance and type 2 diabetes.
Diabetes.
2004;
53
S215-S219
-
37
Young A A, Gedulin B R, Bhavsar S, Bodkin N, Jodka C, Hansen B, Denaro M.
Glucose-lowering and insulin-sensitizing actions of exendin-4: studies in obese diabetic (ob/ob, db/db) mice, diabetic fatty Zucker rats, and diabetic rhesus monkeys (Macaca mulatta).
Diabetes.
1999;
48
1026-1034
-
38
Wang Q, Brubaker P L.
Glucagon-like peptide-1 treatment delays the onset of diabetes in 8 week-old db/db mice.
Diabetologia.
2002;
45
1263-1273
-
39
Antinozzi P A, Segall L, Prentki M, McGarry J D, Newgard C B.
Molecular or pharmacologic perturbation of the link between glucose and lipid metabolism is without effect on glucose-stimulated insulin secretion. A re-evaluation of the long-chain acyl-CoA hypothesis.
J Biol Chem.
1998;
273
16146-16154
-
40
Noel R J, Antinozzi P A, McGarry J D, Newgard C B.
Engineering of glycerol-stimulated insulin secretion in islet beta cells. Differential metabolic fates of glucose and glycerol provide insight into mechanisms of stimulus-secretion coupling.
J Biol Chem.
1997;
272
18621-18627
-
41
Hellmer J, Arner P, Lundin A.
Automatic luminometric kinetic assay of glycerol for lipolysis studies.
Anal Biochem.
1989;
177
132-137
-
42
Kreymann B, Williams G, Ghatei M A, Bloom S R.
Glucagon-like peptide-1 7-36: a physiological incretin in man.
Lancet.
1987;
2
1300-1304
-
43
Fehmann H C, Goke R, Goke B.
Cell and molecular biology of the incretin hormones glucagon-like peptide-I and glucose-dependent insulin releasing polypeptide.
Endocr Rev.
1995;
16
390-410
-
44
Drucker D J.
Biological actions and therapeutic potential of the glucagon-like peptides.
Gastroenterology.
2002;
122
531-544
-
45
Simonsson E, Ahren B.
Potentiated beta-cell response to non-glucose stimuli in insulin-resistant C57BL/6J mice.
Eur J Pharmacol.
1998;
350
243-250
-
46
Malaisse W J, Best L, Kawazu S, Malaisse-Lagae F, Sener A.
The stimulus-secretion coupling of glucose-induced insulin release: fuel metabolism in islets deprived of exogenous nutrient.
Arch Biochem Biophys.
1983;
224
102-110
-
47
Deeney J T, Gromada J, Hoy M, Olsen H L, Rhodes C J, Prentki M, Berggren P O, Corkey B E.
Acute stimulation with long chain acyl-CoA enhances exocytosis in insulin-secreting cells (HIT T-15 and NMRI beta-cells).
J Biol Chem.
2000;
275
9363-9368
-
48
Prentki M, Joly E, El-Assaad W, Roduit R.
Malonyl-CoA signaling, lipid partitioning, and glucolipotoxicity: role in beta-cell adaptation and failure in the etiology of diabetes.
Diabetes.
2002;
51
S405-S413
-
49
Roduit R, Nolan C, Alarcon C, Moore P, Barbeau A, Delghingaro-Augusto V, Przybykowski E, Morin J, Masse F, Massie B, Ruderman N, Rhodes C, Poitout V, Prentki M.
A role for the malonyl-CoA/long-chain acyl-CoA pathway of lipid signaling in the regulation of insulin secretion in response to both fuel and nonfuel stimuli.
Diabetes.
2004;
53
1007-1019
-
50
Ahren B, Pacini G.
Dose-related effects of GLP-1 on insulin secretion, insulin sensitivity, and glucose effectiveness in mice.
Am J Physiol.
1999;
277
E996-E1004
-
51
Greig N H, Holloway H W, de Ore K A, Jani D, Wang Y, Zhou J, Garant M J, Egan J M.
Once daily injection of exendin-4 to diabetic mice achieves long-term beneficial effects on blood glucose concentrations.
Diabetologia.
1999;
42
45-50
-
52
Winzell M S, Svensson H, Arner P, Ahren B, Holm C.
The expression of hormone-sensitive lipase in clonal beta-cells and rat islets is induced by long-term exposure to high glucose.
Diabetes.
2001;
50
2225-2230
-
53
Mulder H, Yang S, Winzell M S, Holm C, Ahren B.
Inhibition of lipase activity and lipolysis in rat islets reduces insulin secretion.
Diabetes.
2004;
53
122-128
-
54
Egan J M, Bulotta A, Hui H, Perfetti R.
GLP-1 receptor agonists are growth and differentiation factors for pancreatic islet beta cells.
Diabetes Metab Res Rev.
2003;
19
115-123
-
55
Perry T, Greig N H.
The glucagon-like peptides: a double-edged therapeutic sword?.
Trends Pharmacol Sci.
2003;
24
377-383
-
56
Ahren B.
Gut peptides and type 2 diabetes mellitus treatment.
Curr Diab Rep.
2003;
3
365-372
-
57
Vilsboll T, Holst J J.
Incretins, insulin secretion and Type 2 diabetes mellitus.
Diabetologia.
2004;
47
357-366
M. Sörhede Winzell
Dept of Medicine, Lund University
BMC, B11 · SE-221 84 Lund · Sweden ·
Phone: +46 (46) 222 0760
Fax: +46 (46) 222 0757
Email: maria.sorhede_winzell@med.lu.se
